Evidence map›Paper›PMID 26331087›Full record

ArticleBiomaterials research2015

Angiogenin-loaded fibrin/bone powder composite scaffold for vascularized bone regeneration.

Beom-Su Kim, Jin-Seong Kim, Sun-Sik Yang, Hyung-Woo Kim, Hun Jun Lim, Jun Lee

Open access · goldAbstract read
In one paragraph

Article in Biomaterials research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Beom-Su KimWonkwang Bone Regeneration Research Institute, Wonkwang University, Iksan, 570-749 Korea ; Bonecell Biotech Inc., Dunsan-dong, Seo-gu, Daejeon, 302-830 Korea.
Jin-Seong KimDepartment of Herbal Crop Research, NIHHS, RDA, Eumseong, 369-873 Korea.
Sun-Sik YangWonkwang Bone Regeneration Research Institute, Wonkwang University, Iksan, 570-749 Korea.
Hyung-Woo KimDepartment of Dentistry, Oral and Maxillofacial, Wonkwang University, Iksan, 570-749 Korea.
Hun Jun LimDepartment of Dentistry, Oral and Maxillofacial, Wonkwang University, Iksan, 570-749 Korea.
Jun LeeWonkwang Bone Regeneration Research Institute, Wonkwang University, Iksan, 570-749 Korea ; Bonecell Biotech Inc., Dunsan-dong, Seo-gu, Daejeon, 302-830 Korea ; Department of Dentistry, Oral and Maxillofacial, Wonkwang University, Iksan, 570-749 Korea.
Wonkwang University · KRCell Biotech (South Korea) · KRNational Institute of Food and Drug Safety Evaluation · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAngiogenin (ANG) is a potent stimulator of angiogenesis. The aim of this study was to fabricate an ANG-loaded scaffold and to evaluate its angiogenic and osteogenic effects. In this study, we fabricated an ANG-loaded scaffold using bovine bone powder and fibrin glue. We then evaluated the structural, morphological, and mechanical properties of the scaffold and the in vitro release profile of ANG. Cell proliferation, viability, and adhesion were evaluated using endothelial cells in vitro, and angiogenesis and new bone formation were evaluated using a rabbit calvarial defect model in vivo.

resultsMicro-computed tomography imaging showed that the bone powder was uniformly distributed in the scaffold, and scanning electron microscopy showed that the bone powder was bridged by polymerized fibrin. The porosity and compressive strength of the scaffolds were ~60 % and ~0.9 MPa, respectively, and were not significantly altered by ANG loading. In vitro, at 7 days, approximately 0.4 μg and 1.3 μg of the ANG were released from the FB/ANG 0.5 and FB/ANG 2.0, respectively and sustained slow release was observed until 25 days. The released ANG stimulated cell proliferation and adherence and was not cytotoxic. Furthermore, in vivo implantation resulted in enhanced angiogenesis, and new bone formation depended on the amount of loaded ANG.

conclusionsThese studies demonstrate that a fibrin and bone powder scaffold loaded with ANG might be useful to promote bone regeneration by enhanced angiogenesis.

Indexed as

AngiogenesisAngiogeninBone regenerationFibrinScaffold

Identifiers

PMID26331087
PMCPMC4552407
OpenAlexW1926182254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.